Eli Lilly to acquire Kelonia Therapeutics in up to $7 billion deal to advance cancer treatment

Asahi Kasei pushes into human trials with new autoimmune drug candidate

The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp

Freudenberg Medical launches CleanAssure cleanroom for sterile single-use assemblies

It is actually a new ISO Class 5 controlled cleanroom designed to deliver washed, dried, and gamma-sterilized single-use assemblies ready for immediate use.

Leinco and CellCarta team up to power next-gen proteomics for cancer and targeted therapies

Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research

Zyax Chem takes 26% stake in Gaymed Labs

Targets high-growth eye care expansion push

Experts discuss ways to strengthen adolescent mental health through ANUMATI 2.0

Policy symposium in Hyderabad focuses on life skills education and community?driven solutions

Blueneem Medical Devices appoints Manoj Tumkur Venkatachala as Chief Product Officer

Manoj has over two decades of experience in healthcare operations and biomedical engineering

Roche’s MS drug fenebrutinib delivers striking Phase III results by cutting relapse rates by 58%

The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints

Moderna launches late-stage trial of mRNA bird flu vaccine

The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone

ENSPRYNG cuts MOGAD relapse risk by 68% in landmark Phase III trial: Roche

The Phase III METEOROID study met its primary endpoint, with ENSPRYNG cutting the risk of a first relapse by 68% compared to placebo in adults and adolescents